The effects of the dysesthesia by a novel transcutaneous electrical nerve stimulation

The effects of the dysesthesia by a novel transcutaneous electrical nerve stimulation - the dysesthesia for a novel TENS

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000045332

Enrollment

Registered

2021-09-02

Start date

2021-08-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diseases by the spinal cord dysfunctions

Interventions

a novel TENS, the stimulus intensity and the frequency of TENS are set to match the intensity and the somatosensory profile of the dysesthesias control high frequency TENS

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) dysesthesia duration of >3 months; (2) a score of >=3 on an 11-point numeric rating scale (NRS, 0 10) for dysesthesia intensity; (3) the ASIA Impairment Scale category C or D.

Exclusion criteria

Exclusion criteria: (1) history of peripheral arterial disease, diabetes, skin disorder, peripheral neuropathy, metabolic disorder, hyperventilation syndrome, amyotrophic lateral sclerosis, Parkinson's disease, autonomic neuropathy, or restless legs syndrome that may cause dysesthesia; (2) <24 on the Mini-Mental State Examination.

Design outcomes

Primary

Measure	Time frame
SF-MPQ2	—

Secondary

Measure	Time frame
ISNCSCI, SCIM, NPSI, SSEP, QST	—

Countries

Japan

Contacts

Public ContactYuki Nishi

Kio University Graduate School of Health Science

y.nishi.pt@gmail.com+81-74-554-1601

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026